Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Wave Life Sciences Ltd (NASDAQ: WVE) closed at $8.09 down -0.49% from its previous closing price of $8.13. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 1.06 million shares were traded. WVE stock price reached its highest trading level at $8.19 during the session, while it also had its lowest trading level at $7.85.
Ratios:
For a deeper understanding of Wave Life Sciences Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.56 and its Current Ratio is at 2.56. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on August 04, 2025, initiated with a Buy rating and assigned the stock a target price of $19.
On July 28, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $24.
On July 16, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $16.Citigroup initiated its Buy rating on July 16, 2025, with a $16 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 05 ’25 when TAKANASHI KEN sold 4,872 shares for $8.75 per share. The transaction valued at 42,630 led to the insider holds 5,716,303 shares of the business.
Tan Aik Na sold 1,127 shares of WVE for $9,861 on Aug 05 ’25. The Director now owns 14,988 shares after completing the transaction at $8.75 per share. On Jun 13 ’25, another insider, Verdine Gregory L., who serves as the Director of the company, sold 30,000 shares for $6.95 each. As a result, the insider received 208,500 and left with 282,517 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1287442688 and an Enterprise Value of 1108550272. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.70 while its Price-to-Book (P/B) ratio in mrq is 9.04. Its current Enterprise Value per Revenue stands at 11.8 whereas that against EBITDA is -7.923.
Stock Price History:
The Beta on a monthly basis for WVE is -1.17, which has changed by 0.50651765 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $5.04. The 50-Day Moving Average of the stock is 8.97%, while the 200-Day Moving Average is calculated to be -19.28%.
Shares Statistics:
For the past three months, WVE has traded an average of 1.33M shares per day and 1591520 over the past ten days. A total of 155.67M shares are outstanding, with a floating share count of 127.12M. Insiders hold about 20.12% of the company’s shares, while institutions hold 79.07% stake in the company. Shares short for WVE as of 1752537600 were 16405588 with a Short Ratio of 12.30, compared to 1749772800 on 14881762. Therefore, it implies a Short% of Shares Outstanding of 16405588 and a Short% of Float of 14.37.
Earnings Estimates
A detailed examination of Wave Life Sciences Ltd (WVE) is currently in progress, with 12.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.09 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$0.92 and -$1.42 for the fiscal current year, implying an average EPS of -$1.15. EPS for the following year is -$1.2, with 12.0 analysts recommending between -$0.85 and -$1.77.
Revenue Estimates
A total of 14 analysts have provided revenue estimates for WVE’s current fiscal year. The highest revenue estimate was $85M, while the lowest revenue estimate was $17.87M, resulting in an average revenue estimate of $46.77M. In the same quarter a year ago, actual revenue was $108.3M
